Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms. Shah MV, Chhetri R, Dholakia R, Kok CH, et al. Am J Hematol 2022;97:1013-1022.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shah MV, Chhetri R, Dholakia R, Kok CH, et al. Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms. Am J Hematol 2022;97:1013-1022.
PMID: 35560061